Publications
5891 Results
- Journal / Conference
- Radiotherapy and Oncology 88(S2):S148(449)
- Year
- 2008
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794
Updated results of SWOG 8794: adjuvant radiation for high risk prostate cancer
- Journal / Conference
- Radiotherapy and Oncology 88(S2):S337(1057)
- Year
- 2008
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794
Prognostic significance of pathologic SV involvement and the effect of adjuvant radiation therapy on outcome
- Journal / Conference
- International Journal of Radiation Oncology Biology Physics 72(1)suppl. 1:S31
- Year
- 2008
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794
Update of SWOG 8794: adjuvant radiotherapy of pT3 prostate cancer improves metastasis free survival
- Journal / Conference
- Blood 112(11)181 abst. 475
- Year
- 2008
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Molecular signatures implicate innate immune cells, fibrosis, and angiogenesis in survival following R-CHOP treatment of diffuse large B cell lymphoma
- Journal / Conference
- Blood 112(11):196 Abst. 520
- Year
- 2008
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Genome-wide expression profiling predicts treatment outcome in classical hodgkin lymphoma
- Journal / Conference
- Blood 112(11):714, Abst. 2049
- Year
- 2008
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Genetic abnormalities involved in the development and progression of follicular lymphoma
- Journal / Conference
- San Antonio Breast Cancer Symposium, Abstract #76
- Year
- 2008
- Research Committee(s)
- Breast
NSABP B-30: definitive analysis of quality of life (QOL) and menstrual history (MH) outcomes from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclosphosphamide in women with operable, node positive breast cancer
- Journal / Conference
- Gynecologic Oncology 108(3) suppl. 1:S3
- Year
- 2008
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S0009
Phase II evaluation of neoadjuvant chemotherapy and interval debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube, or primary peritoneal cancer: A Southwest Oncology Group study
- Journal / Conference
- Journal of Clinical Oncology 26(25):5802-5812
- Year
- 2008
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)